Actionable news
All posts from Actionable news
Actionable news in ABBV: ABBVIE Inc,

AbbVie Ordered to Pay $150 Million Damages in ‘Low-T’ Trial

  • Verdict is first against company over testosterone booster
  • Oregon man blamed heart attack on AbbVie’s AndroGel product

AbbVie Inc. was ordered to pay $150 million to an Oregon man who accused the drugmaker of hiding the heart-attack risks of its AndroGel testosterone booster, a loss for the company in the first case to be weighed by jurors over what was once one of its top-selling products.

AbbVie misled Jesse Mitchell and his doctor about AndroGel’s propensity for causing blood clots, which can lead to fatal heart attacks, a federal court jury in Chicago concluded Monday. Mitchell, a 54-year-old laundry manager, suffered a heart attack in 2012 after taking AndroGel for four years.